πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Jazz Pharmaceuticals Ireland Patents

Full USPTO pharma patent portfolio for Jazz Pharmaceuticals Ireland β€” grant dates, expiration, and drug cross-links.

Patents
89
Expiring ≀24m
0

Quick answer

Jazz Pharmaceuticals Ireland has 89 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 2

  1. US 10758488

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10710958

    Carbamoyl phenylalaninol compounds and uses thereof

    Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10675258

    Method of using gamma-hydroxybutyrate compositions for the treatment of disorders

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10512609

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10398662

    GHB formulation and method for its manufacture

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10259780

    Treatment of cataplexy

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10213400

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10195151

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10195168

    Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10174302

    Modified L-asparaginase

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10105341

    Treatment for obesity

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9920311

    PEGylated L-asparaginase

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9801852

    Devices and methods for facilitating and controlling use of a medication

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9795567

    Immediate release formulations and dosage forms of gamma-hydroxybutyrate

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9707270

    Method for administering Ο‰-conopeptide

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9649291

    Treatment for obesity

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9585863

    Treatment of cataplexy

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9555017

    Methods of making a mixture of salts of gamma-hydroxybutyrate

    Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9539330

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9486426

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9359290

    Treatment of cataplexy

    Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9226910

    Treatment for obesity

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9132107

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9050302

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8952029

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8952062

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8901173

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8859619

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8778398

    Immediate release formulations and dosage forms of gamma-hydroxybutyrate

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8771735

    Immediate release dosage forms of sodium oxybate

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8772306

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8765680

    Method for administering omega-conopeptide

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8716279

    Pharmaceutical compositions of clonazepam and method of use thereof

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8653033

    Method for administering omega-conopeptide

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8609651

    Pharmaceutical compositions of benzodiazepines and method of use thereof

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8591922

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8513198

    Pharmaceutical formulation for reducing pain

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8461203

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8324275

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8263650

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7851506

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Jazz Pharmaceuticals Ireland have?

89 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Jazz Pharmaceuticals Ireland patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.